NASDAQ · Drug Manufacturers - Specialty & Generic

TKNO (TKNO) Stock

$4.96 +2.16% NASDAQ: TKNO Healthcare

Valuation

MetricValue
Price$4.96
Market Cap$265.66M
P/E Ratio-16.86
P/B Ratio3.22
P/S Ratio5.30
EPS (TTM)$-0.32
52-Week High$6.68
52-Week Low$1.91
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-23.92%
ROA-9.29%
ROCE-24.64%
Gross Margin33.33%
Operating Margin-39.02%
Net Margin-41.07%
Debt/Equity0.23
Current Ratio4.38

Annual Financials (USD)

Metric20212022202320242025
Revenue$37.0M$41.0M$37.0M$38.0M$41.0M
Operating Profit$-12.0M$-50.0M$-36.0M$-26.0M$-17.0M
Net Profit$-10.0M$-47.0M$-37.0M$-27.0M$-17.0M
EPS$-0.35$-1.69$-1.16$-0.57$-0.32
Op Margin-32.5%-119.9%-96.9%-69.3%-41.9%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$167.0M$152.0M$129.0M$119.0M$104.0M
Total Liabilities$23.0M$52.0M$39.0M$36.0M$35.0M
Cash$88.0M$42.0M$28.0M$4.0M$6.0M
Borrowings$12.0M$42.0M$30.0M$30.0M$15.0M

Latest News

Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026 GlobeNewswire · Jul 22, 2026 May 2026's Promising Penny Stocks To Watch Simply Wall St. · May 28, 2026 Alpha Teknova, Inc. (NASDAQ:TKNO) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates Simply Wall St. · May 9, 2026 Alpha Teknova Q1 Earnings Call Highlights MarketBeat · May 7, 2026 Alpha Teknova, Inc. Q1 2026 Earnings Call Summary Moby · May 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-9.0M$-27.0M$-19.0M$-12.0M$-9.0M
Investing Cash Flow$-37.0M$-56.0M$-16.0M$-28.0M$10.0M
Financing Cash Flow$-4.0M$0$0$0$-1.0M
Net Cash Flow$84.0M$-45.0M$-14.0M$-25.0M$2.0M
Free Cash Flow$-29.0M$-56.0M$-27.0M$-14.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-47.53
EV / EBITDA-24.44
FCF Yield-4.00%
Quick Ratio3.60
Interest Coverage-17.00
Return 1Y1.96%
Return 3Y51.38%
Return 5Y-74.09%

Ownership

Insiders Held9.32%
Institutions Held84.68%
Institutions Float Held93.39%
Institutional HolderSharesReport Date
Roubaix Capital, LLC1,882,3552026-03-31
Royce & Associates LP1,069,1622026-03-31
Blackrock Inc.716,7742026-03-31
Millennium Management Llc447,1382026-03-31
Vanguard Capital Management LLC441,8792026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACB $2.72 -0.73% 115.33 $168.48M 0.00%
BIOA $20.88 -4.09% -9.34 $786.12M 0.00%
CGC $0.92 +4.02% -0.20 $390.20M 0.00%
CVRX $4.88 +2.95% -2.98 $129.50M 0.00%
IMMPImmutep Limited $0.44 +0.90% -0.94 $64.36M 0.00%

About TKNO

TKNO is led by CEO Stephen Gunstream, employs 173 people, headquartered in US, publicly traded since 2021.

TKNO stock trades at $4.96 with a market capitalization of $265.66M. The stock is valued at a price-to-earnings (P/E) ratio of -16.86, price-to-book of 3.22, price-to-sales of 5.30. Over the past 52 weeks the stock has ranged between $1.91 and $6.68, and currently trades 25.7% below its 52-week high.

On profitability, TKNO generates a return on equity (ROE) of -23.92%, return on capital employed of -24.64%, an operating margin of -39.02%, a net profit margin of -41.07%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides